| Abstrakt: |
This article presents summary of articles, on healthcare systems to treat multiple sclerosis (MS). Treatment of significant acute relapses in MS is known to accelerate recovery and improve quality of life. A rapid access multi-disciplinary MS clinic has been established in order to improve the assessment of new MS-related symptoms and speed up appropriate treatment. Advances in biotechnology have led to an enhanced understanding of the complex pathophysiology of MS and more treatment options for this disease. patients and anticipated infusion needs. With proper utilization of medications and precise coding, reimbursements cover the costs of the infusion, personnel, and supplies, with a small to moderate profit margin depending upon the type of drug administered. It is unclear what model of service delivery should be used for responding to relapse of MS. Health systems should meet the needs of these patients in a responsive and effective manner by combining access to both intravenous methylprednisolone and a multidisciplinary team. |
